James R. Kasinger

General Counsel and Secretary, CRISPR Therapeutics AG

Bought, 12 months

$0.0M

Sold, 12 months

$1.4M

Companies

Latest trade

Oct 14, 2026

Companies

CRISPR Therapeutics AGGeneral Counsel and Secretary −$1.4M

Trades

CRSP Sold 1,040 shares at $49.26 $0.1M Oct 14

CRSP Sold 1,990 shares at $60.04 · planned $0.1M Oct 6

CRSP Sold 10,400 shares at $60.24 · planned $0.6M Sep 22

CRSP Sold 3,182 shares at $46.78 $0.1M Mar 23

CRSP Sold 3,450 shares at $48.26 $0.2M Mar 16

CRSP Sold 2,800 shares at $52.80 $0.1M Mar 11

CRSP Sold 2,112 shares at $52.58 $0.1M Feb 19

CRSP Sold 1,076 shares at $66.60 $0.1M Oct 14

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.